Advance Search
ZHUO Zhiyuan, LI Ke. Comparison of two second-line chemotherapy regimens for relapsed and refractory small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 122-126. DOI: 10.7619/jcmp.202017033
Citation: ZHUO Zhiyuan, LI Ke. Comparison of two second-line chemotherapy regimens for relapsed and refractory small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 122-126. DOI: 10.7619/jcmp.202017033
shu

Comparison of two second-line chemotherapy regimens for relapsed and refractory small cell lung cancer

  • Department of Respiratory and Critical Care Medicine, Xuzhou City Central Hospital, Xuzhou, Jiangsu, 221009

More Information
  • Received Date: July 25, 2020
  • Available Online: September 29, 2020
    Graphical Abstract
    • Abstract
  • Objective To compare the safety and efficacy of irinotecan combined with cisplatin chemotherapy(IP)and paclitaxel combined with cisplatin chemotherapy(TP)in second-line treatments for patients with relapsed and refractory small cell lung cancer. Methods A total of 53 patients with relapsed and refractory small cell lung cancer were randomly divided into IP group(n=29)and TP group(n=24), and the short-term and long-term efficacy and adverse reactions of the two groups were compared. Results The median progression-free survival time(PFS)of the IP group and the TP group were 4.5 months and 3.5 months, and the median overall survival time(OS)was 10 months and 9 months, respectively, and there were no significant differences between the two groups(P>0.05). Physical status(PS)score before receiving second-line treatment was an independent prognostic factor of PFS with irinotecan or paclitaxel combined with cisplatin chemotherapy(P<0.05); PS score before receiving second-line treatment and bone metastasis were independent prognostic factors of survival time(OS). The incidence of delayed-onset diarrhea in the IP group was significantly higher than that in the TP group(P<0.05). The incidence rates of numbness and joint pain in the TP group were significantly higher than that in the IP group(P<0.05). Conclusion Cisplatin combined with irinotecan or paclitaxel have similar efficacy and similar safety.
    • FullText(HTML)
    • References (18)
  • FERLAY J, SHIN H R, BRAY F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12): 2893-2917.
    崔晓霞, 宋鹏, 张力. 小细胞肺癌诊疗新进展[J]. 中国肺癌杂志, 2019, 22(6): 355-362.
    Glisson B S. Recurrent small cell lung cancer: Update[J]. Semin Oncol, 2003, 30(1): 72-78.
    李丽, 孙健, 张有为, 等. 小细胞肺癌二线化疗药物的应用进展[J]. 实用癌症杂志, 2019, 34(2): 343-345.
    EISENHAUER E A, THERASSE P, BOGAERTS J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline(version 1.1)[J]. Eur J Cancer, 2009, 45(2): 228-247.
    O'BRIEN M E R, CIULEANU T E, TSEKOV H, et al. Phase Ⅲ trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer[J]. J Clin Oncol, 2006, 24(34): 5441-5447.
    SHIOZAWA T, SEKINE I, AIDA Y K, et al. Rechallenge with first-line platinum chemotherapy for sensitive-relapsed small-cell lung cancer[J]. Case Rep Oncol, 2018, 11(3): 622-632.
    SAIJO A, HANIBUCHI M, OGINO H, et al. Paclitaxel for relapsed small-cell lung cancer patients with idiopathic interstitial pneumonias[J]. Mol Clin Oncol, 2019, 10(5): 541–546.
    WAKUDA K, MIYAWAKI T, MIYAWAKI E, et al. Efficacy of second-line chemotherapy in patients with sensitive relapsed small-cell lung cancer[J]. Vivo, 2019, 33(6): 2229-2234.
    VAN DER LEE I, SMIT E F, VAN PUTTEN J W, et al. Single-agent gemcitabine in patients with resistant small-cell lung cancer[J]. Ann Oncol, 2001, 12(4): 557-561.
    NAIR B S, BHANDERI V, JAFRI S H. Current and emerging pharmacotherapies for the treatment of relapsed small cell lung cancer[J]. Clin Med Insights Oncol, 2011, 5: 223-234.
    HIROSE T, HORICHI N, OHMORI T, et al. Phase Ⅱ study of irinotecan and carboplatin in patients with the refractory or relapse small cell lung cancer [J]. Lung Cancer, 2003, 40(3): 333-338.
    FUJITA A, TAKABATAKE H, TAGAKI S, et al. Pilot study of irinotecan in refractory small cell lung cancer [J]. Gan To Kagaku Ryoho, 1995, 22(7): 889-893.
    MASUDA N, FUKUOKA M, KUSUNOKI Y, et al. CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer[J]. J Clin Oncol, 1992, 10(8): 1225-1229.
    SEVINC A, KALENDER M E, ALTINBAS M, et al. Irinotecan as a second-line monotherapy for small cell lung cancer[J]. Asian Pac J Cancer Prev, 2011, 12(4): 1055-1059.
    陈炎, 陈亚蓓, 陶荣芳. 《CSCO原发性肺癌诊疗指南2016》小细胞肺癌治疗内容介绍[J]. 中国实用内科杂志, 2017, 37(S1): 42-43.
    YAMAMOTO N, TSURUTANI J, YOSHIMURA N, et al. Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancer[J]. Anticancer Res, 2006, 26(1b): 777-781.
    RAMALINGAM S S, FOSTER J, GOODING W, et al. Phase 2 study of irinotecan and paclitaxel in patients with recurrent or refractory small cell lung cancer[J]. Cancer, 2010, 116(5): 1344-1349.
    • Related Articles

  • Related Articles

    [1]XU Mingkui, CHEN Meixiong, XU Riming, LIN Yewu, LUO Yuantai, CHEN Yingwei, ZHOU Li. Clinical efficacy of minimally invasive transforaminal lumbar interbody fusion by lower Quadrant channel through the muscle gap approach in treatment of lumbar degenerative disease[J]. Journal of Clinical Medicine in Practice, 2022, 26(11): 94-99. DOI: 10.7619/jcmp.20214699
    [2]TAN Fang, WANG Jian, ZHANG Feng, HAN Shuai, SONG Xin, LI Kai. Clinical efficacy of minimally invasive surgery transforaminal lumbar interbody fusion in treatment of upper lumbar disc herniation[J]. Journal of Clinical Medicine in Practice, 2021, 25(12): 42-45. DOI: 10.7619/jcmp.20210644
    [3]FEI Yanqiang, LI Xiaolong, JIANG Wenchao, GAO Xin. Middle and long-term clinical efficacy of modified transforaminal lumbar interbody fusion in the treatment of lumbar spondylolisthesis[J]. Journal of Clinical Medicine in Practice, 2020, 24(16): 74-76,81. DOI: 10.7619/jcmp.202016021
    [4]YAO Shixiang. Percutaneous one-way solid pedicle screw fixationversus pedicle screw fixation in treating patients with thoracolumbar fracture[J]. Journal of Clinical Medicine in Practice, 2019, 23(9): 27-30. DOI: 10.7619/jcmp.201909008
    [5]WANG Yuqiang, JIN Haichao, LI Zhonghai, LI He, SU Xuetao. Curative effect of MI-TLIF under expansion channel combined with pedicle screw fixation on treatment of patients with lumbar degenerative scoliosis complicated with spinal stenosis[J]. Journal of Clinical Medicine in Practice, 2017, (7): 67-70. DOI: 10.7619/jcmp.201707018
    [6]ZHAO Yihong, GAO Junmao, HE Heliang. Long-term efficacy of small target region intensity-modulated radiotherapy and chemotherapy in treatment of patients with nasopharyngeal cancer[J]. Journal of Clinical Medicine in Practice, 2015, (21): 73-76. DOI: 10.7619/jcmp.201521020
    [7]LI Jun, WANG Jieyan. Efficacy observation of pedicle screw fixation and posterior interbody fusion in the treatment of 80 patients with lumbar spondylolisthesis[J]. Journal of Clinical Medicine in Practice, 2014, (16): 93-95. DOI: 10.7619/jcmp.201416027
    [8]WANG Xiaolin. Comparison of long-term effects between Cage combined with pedicle screw fixation and bone grafting combined with pedicle screw fixation in treatment of patients with lumbar spondylolisthesis[J]. Journal of Clinical Medicine in Practice, 2014, (15): 38-41. DOI: 10.7619/jcmp.201415012
    [9]LI Yi. Clinical study of spinal interbody fusion with pedicle screw rod system fixation and laminectomy in treating elderly degenerative lumbar spondylolisthesis[J]. Journal of Clinical Medicine in Practice, 2013, (7): 69-71,78. DOI: 10.7619/jcmp.201307022
    [10]ZUO Hua, HUANG Yong-hui, DING Liang. Observation of clinical effect of unilateral pedicle screw fixation with intervertebral morselized bone body fusion after decompression in treating degenerative lumbar instability[J]. Journal of Clinical Medicine in Practice, 2011, (21): 26-28. DOI: 10.3969/j.issn.1672-2353.2011.21.008

  • Cited by

    Periodical cited type(29)

    1. 张婷，张苗苗. 分级分区护理管理模式对急性心肌梗死患者心功能及预后的改善作用. 临床医学研究与实践. 2022(16): 169-171 .
    2. 朱勇. 医疗失效模式与效应分析法优化急救流程在急性心肌梗死行急诊PCI患者中的应用效果. 中国民康医学. 2021(17): 148-150 .
    3. 张霞，吕艳梅，王丽绒，韩月. 胸痛中心再灌注救治流程护理对急性心肌梗死患者救治成功率的影响. 临床医药文献电子杂志. 2020(04): 113-114 .
    4. 朱慧瑜. 胸痛中心急救护理路径对STEMI患者诊治效果的影响. 心血管病防治知识(学术版). 2020(01): 75-77 .
    5. 盛亚萍，邹姣. 胸痛中心管理模式下的急救护理路径对ST段抬高型心肌梗死患者救治效率及效果的影响. 国际护理学杂志. 2020(05): 892-894 .
    6. 王召义，马懿，许官学. 区域协同救治体系的建立及其推动基层胸痛中心建设的意义. 海南医学. 2020(09): 1179-1182 .
    7. 谢索. 胸痛中心再灌注救治流程护理在急性心肌梗死患者中的护理效果. 心血管病防治知识(学术版). 2020(10): 89-91 .
    8. 邓金梅，吴燕群，陈银花. 急性ST段抬高型心肌梗死患者应用胸痛中心(CPC)再灌注救治流程护理的价值分析. 中外医疗. 2020(14): 161-163 .
    9. 刘海龙. 胸痛中心对心肌梗死急诊介入时间的临床影响研究. 当代医学. 2020(33): 68-70 .
    10. 李利群，林海云，黄风莲，李凤云. 基层胸痛中心建设对急性心肌梗死救治的意义. 中国城乡企业卫生. 2019(02): 4-6 .
    11. 杨菁，金明，高斌，仲淑燕. 实施胸痛中心护理机制对心血管疾病患者抢救效率的影响. 广西医学. 2019(04): 533-535 .
    12. 周强. 胸痛中心再灌注救治流程护理对急性心肌梗死患者救治成功率的影响. 家庭生活指南. 2019(02): 284 .
    13. 许丽丽，王秀精，邱敏玲. 急诊全程综合护理干预对急性心肌梗死患者救治效果影响分析. 中外医学研究. 2019(18): 105-107 .
    14. 黎德庆，刘子永. 胸痛中心建立对区域内急性ST段抬高型心肌梗死患者救治效果的影响. 中国当代医药. 2019(16): 31-34 .
    15. 谢丽芬，张伟泰，丘夏玲. 胸痛中心再灌注救治流程护理在急性心肌梗死患者中的应用效果. 中国当代医药. 2019(17): 220-222 .
    16. 刘毅蓉. 胸痛中心再灌注救治流程护理对急性心肌梗死患者救治成功率的影响. 世界最新医学信息文摘. 2019(67): 320-321 .
    17. 郝清云. 再灌注救治流程护理对提升急性心肌梗死患者救治成功率的效果分析. 中国医药指南. 2019(24): 208-209 .
    18. 黄金链. 急性胸痛患者有效的抢救护理方法及效果探讨. 医学食疗与健康. 2019(11): 136+139 .
    19. 李燕珍，胡良巧. 优化急诊护理流程对急诊胸痛患者抢救的效果. 卫生职业教育. 2019(23): 155-156 .
    20. 翟旭莉. 胸痛中心再灌注救治流程护理对急性心肌梗死患者救治成功率的影响分析. 世界最新医学信息文摘. 2019(A0): 224-225 .
    21. 向阳. 胸痛中心对急性心肌梗死患者抢救效果的影响研究. 中国社区医师. 2019(33): 75+77 .
    22. 苏秀娜，朱时法. 胸痛中心急性心肌梗死患者行再灌注救治流程护理的心得体会. 心血管病防治知识(学术版). 2019(21): 48-50 .
    23. 王春梅，徐琴，彭利芳，黄蔚萍. 胸痛中心建设中优化护理流程的实践与探索. 当代护士(上旬刊). 2018(06): 179-181 .
    24. 钟凤琼，祖木拉提·胡甫尔. 优化急救护理流程对急性心肌梗死患者救治的影响. 临床医药文献电子杂志. 2018(77): 108+121 .
    25. 刘冬兰. 胸痛中心再灌注救治流程在ST段抬高型心肌梗死患者中的影响. 实用临床护理学电子杂志. 2018(40): 109-110 .
    26. 韩志领，王丽娟，王建慧. 成立胸痛中心对救治急性ST段抬高型心肌梗死患者的影响. 实用中西医结合临床. 2018(09): 21-23 .
    27. 李小芬，丁玲，刘祺. 全程介入护理在急性心肌梗死经桡动脉行急诊经皮冠状动脉介入治疗患者的应用效果. 中西医结合心血管病电子杂志. 2018(29): 89-91 .
    28. 吕月平，关丽荣. 基层胸痛中心优化护理急救流程的建立及其在AMI患者救治中的应用. 系统医学. 2018(20): 196-198 .
    29. 赵成红. 优化护理在心肌梗死PCI患者中的临床应用观察及疗效分析. 世界最新医学信息文摘. 2018(93): 4-5 .

    Other cited types(6)

Catalog

    Get Citation
    PDF
    XML
    Article views (402) PDF downloads (12) Cited by(35)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return